Harris; Joel M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Harris; Joel M..The latest application filed is for "clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device".

Company Profile

3.28.30

Harris; Joel M. - Mountain View CA
Harris; Joel M. - Blaine MN
Harris; Joel M. - Minnetonka MN US
Harris; Joel M. - Salt Lake City UT US
Harris; Joel M. - Kenilworth NJ US
Harris; Joel M. - Summit NJ
Harris; Joel M. - Watchung NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Clotting Factor Preparations For Delivery Into Tissue Of The Intestinal Tract Using A Swallowable Drug Delivery Device App 20200222318 - Imran; Mir ; et al.	2020-07-16
Systems and methods for delivering sensory input during a dream state Grant 10,685,577 - Imran , et al.	2020-06-16
Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device Grant 10,603,275 - Imran , et al.	2020-03-31
Systems and methods for delivering sensory input during a dream state Grant 10,242,585 - Imran , et al.	2019-03-26
System And Method For Delivery Of A Therapeutic Agent To The Inner Ear App 20190038469 - Imran; Mir A. ; et al.	2019-02-07
Systems And Methods For Delivering Sensory Input During A Dream State App 20190019427 - Imran; Mir ; et al.	2019-01-17
Systems and methods for delivering sensory input during a dream state Grant 10,019,908 - Imran , et al. July 10, 2	2018-07-10
Systems And Methods For Delivering Sensory Input During A Dream State App 20170270810 - Imran; Mir ; et al.	2017-09-21
Systems and methods for delivering sensory input during a dream state Grant 9,620,027 - Imran , et al. April 11, 2	2017-04-11
Compounds inhibiting leucine-rich repeat kinase enzyme activity Grant 9,440,952 - Miller , et al. September 13, 2	2016-09-13
Bridged bicyclic piperidine derivatives and methods of use thereof Grant 9,409,918 - Harris , et al. August 9, 2	2016-08-09
Method Of Making Hollow Fiber Membrane Modules With A Curable Composition And Modules Made Therefrom App 20160096142 - HARRIS; JOEL M. ; et al.	2016-04-07
Method Of Making Spiral Wound Filtration Modules With A Curable Adhesive Composition And Modules Made Thereby App 20160096144 - HARRIS; JOEL M. ; et al.	2016-04-07
Substituted biaryl derivatives and methods of use thereof Grant 9,301,929 - Boyle , et al. April 5, 2	2016-04-05
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity App 20160009682 - Miller; Michael ; et al.	2016-01-14
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment Grant 8,957,062 - Edmondson , et al. February 17, 2	2015-02-17
Systems and Methods for Delivering Sensory Input During a Dream State App 20140342338 - Imran; Mir ; et al.	2014-11-20
Systems and Methods for Delivering Sensory Input During a Dream State App 20140343353 - Imran; Mir ; et al.	2014-11-20
Substituted Cycloproply Compounds, Compositions Containing Such Compounds And Methods Of Treatment App 20140057893 - Edmondson; Scott ; et al.	2014-02-27
Surfaces resistant to non-specific protein adsorption and methods of producing the same Grant 8,470,247 - Harris , et al. June 25, 2	2013-06-25
Substituted [1,2,4]triazolo[4,3-alpha]quinoxalines as adenosine A2a receptor antagonists Grant 8,435,994 - Harris , et al. May 7, 2	2013-05-07
Amino-quinoxaline and amino-quinoline compounds for use as adenosine A.sub.2a receptor antagonists Grant 8,415,353 - Harris , et al. April 9, 2	2013-04-09
Bicyclic heterocycle derivatives and methods of use thereof Grant 8,410,122 - Harris , et al. April 2, 2	2013-04-02
FUSED TRICYCLIC COMPOUNDS WITH ADENOSINE A2a RECEPTOR ANTAGONIST ACTIVITY App 20120232086 - Harris; Joel M. ; et al.	2012-09-13
Substituted Biaryl Derivatives And Methods Of Use Thereof App 20120220614 - Boyle; Craig D. ; et al.	2012-08-30
Bridged Bicyclic Piperidine Derivatives And Methods Of Use Thereof App 20120214805 - Harris; Joel M. ; et al.	2012-08-23
Methods And Compositions For Measuring High Affinity Interactions With Kinetic Imaging Of Single Molecule Interaction (kismi) App 20120208291 - Davis; M. Wayne ; et al.	2012-08-16
1,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo[4,3-e]-1,2,4-triazolo[4,3-c]pyrimidin-3-one compounds for use as adenosine A.sub.2a receptor antagonists Grant 8,222,259 - Harris , et al. July 17, 2	2012-07-17
Nanonized Iron Compositions and Methods of Use Thereof App 20120177700 - Imran; Mir A. ; et al.	2012-07-12
Bridged Bicyclic Heterocycle Derivatives And Methods Of Use Thereof App 20120040975 - Neelamkavil; Santhosh Francis ; et al.	2012-02-16
Bicyclic Heterocycle Derivatives And Methods Of Use Thereof App 20110263624 - Harris; Joel M. ; et al.	2011-10-27
1,2,4-TRIAZOLO[4,3-c]PYRIMIDIN-3-ONE AND PYRAZOLO[4,3-e]-1,2,4-TRIAZOLO[4,3-c]PYRIMIDIN-3-ONE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS App 20110152256 - Harris; Joel M. ; et al.	2011-06-23
Bicyclic Heterocycle Derivatives And Their Use As Gpcr Modulators App 20110118286 - Neelamkavil; Santhosh Francis ; et al.	2011-05-19
AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS App 20110105513 - Harris; Joel M. ; et al.	2011-05-05
Bicyclic Heterocycle Derivatives And Use Thereof As Gpr119 Modulators App 20110065671 - Harris; Joel M. ; et al.	2011-03-17
Azetidinone derivatives and methods of use thereof Grant 7,884,080 - Aslanian , et al. February 8, 2	2011-02-08
Pyrimidinone Derivatives And Methods Of Use Thereof App 20100190687 - Boyle; Craig D. ; et al.	2010-07-29
Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A.sub.2a receptor antagonists Grant 7,709,492 - Neustadt , et al. May 4, 2	2010-05-04
Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism Grant 7,638,526 - McKittrick , et al. December 29, 2	2009-12-29
Surfaces Resistant to Non-Specific Protein Adsorption and Methods of Producing the Same App 20090175765 - Harris; Joel M. ; et al.	2009-07-09
2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists Grant 7,465,740 - Neustadt , et al. December 16, 2	2008-12-16
Azetidine Derivatives Useful In Treating Pain, Diabetes And Disorders Of Lipid Metabolism App 20080089858 - McKittrick; Brian A. ; et al.	2008-04-17
Azetidinone Derivatives and Methods of Use Thereof App 20080076750 - Aslanian; Robert G. ; et al.	2008-03-27
Azetidinone Derivatives and Methods of Use Thereof App 20080076751 - Aslanian; Robert G. ; et al.	2008-03-27
Treating Pain, Diabetes, And Disorders Of Lipid Metabolism App 20080070892 - Harris; Joel M. ; et al.	2008-03-20
2-Heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists App 20070066620 - Neustadt; Bernard R. ; et al.	2007-03-22
Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists App 20050239795 - Neustadt, Bernard R. ; et al.	2005-10-27
Raman spectroscopy apparatus and method for continuous chemical analysis of fluid streams Grant 5,751,415 - Smith , et al. May 12, 1	1998-05-12
Gas analysis system having buffer gas inputs to protect associated optical elements Grant 5,135,304 - Miles , et al. August 4, 1	1992-08-04
Multichannel detection and resolution of chromatographic peaks Grant 4,353,242 - Harris , et al. October 12, 1	1982-10-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.